Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Podobne zapisy

• Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
  od: Mukhtyar, C, i wsp.
  Wydane: (2006)
• Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
  od: Mukhtyar, C, i wsp.
  Wydane: (2008)
• Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
  od: Saket Jha, i wsp.
  Wydane: (2019-01-01)
• Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
  od: Zhi-Ying Li, i wsp.
  Wydane: (2020-08-01)
• Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
  od: Moog P, i wsp.
  Wydane: (2015-11-01)